Research

Researchers find key to making transplant rejection a thing of the past

Study reveals pathway to targeting master regulator of T-cell function


Resized_20_Wenhao_Chen_Xian_Li_LabAction__DSC8696_Edit
By Lisa K. Merkl | January 08, 2018

Houston Methodist researchers have cracked a code in T-cells that could make autoimmune diseases and organ transplant rejection a thing of the past.

Wenhao Chen, Ph.D., a scientist in the Immunobiology and Transplant Science Center at the Houston Methodist Research Institute, and his colleagues have identified a critical switch that controls T-cell function and dysfunction and have discovered a pathway to target it.

Their findings are described in an article titled “Ablation of Transcription Factor IRF4 Promotes Transplant Acceptance by Driving Allogenic CD4+ T Cell Dysfunction” in the Dec. 19 issue of Immunity, a top medical journal of immunology published by Cell Press.

T-cells, which are a type of white blood cells that protect the body from infection, play a central role not only in infections, but also autoimmune diseases and transplant rejection. Understanding how T-cells work is of critical importance for treating these diseases. Chen and his team are doing this by systematically deleting different molecules in T-cells to check which ones are required for the T-cells to function.

What they have found is that one of the most critical molecules controlling gene expression in T-cells is the transcription factor IRF4, which is usually only found in the immune system and not expressed in other cells. Chen says IRF4 is what needs to be targeted to solve the problem of transplant rejection or to develop an autoimmunity cure.

“We found that IRF4 is an essential regulator of T-cell function,” said Chen, who is the corresponding author on this paper. “If we delete IRF4 in T-cells they become dysfunctional. In doing so, you can solve the issue of autoimmunity and have a potential solution for organ transplant rejection. You need them functional, however, to control infection. If we can find an IRF4 inhibitor, then those issues would be solved. That’s big.”

The way they will be able to do this is by only targeting active T-cells that have already been exposed to antigens, leaving the so-called naïve T-cells — those that have never seen antigens and produce no or little IRF4 – alone. These naïve T-cells produce IRF4 only when needed to fight infections. It’s the activated T-cells armed with IRF4 that are responsible for organ transplant rejection and autoimmunity. These, he says, are the ones that are a potential target, thereby leaving other T cells in the immune system still armed against infection.

Their initial results were promising. By inhibiting IRF4 expression for 30 days – the usual timeframe required for transplant patients to remain infection free – the T-cells became irreversibly dysfunctional. In practice, this could mean prolonging a patient’s ability to tolerate a transplanted organ.

“How to therapeutically inhibit IRF4 is the Nobel-prize winning question,” Chen said. “If we can find a way to inhibit IRF4 as desired in activated T-cells, then I think most autoimmune diseases and transplant rejection will be solved.”

Researchers collaborating with Chen on this paper include Jie Wu, Hedong Zhang, Xiaomin Shi, Xiang Xiao, Yihui Fan, Laurie J. Minze, Jin Wang, Rafik M. Ghobrial, Roger Sciammas and Xian C. Li with the Immunobiology & Transplant Science Center at Houston Methodist Research Institute; and Jiahong Xia with the Department of Cardiovascular Surgery at Union Hospital at Huazhong University of Science and Technology in China.

The work was supported by a grant from the American Heart Association (11SDG7690000), startup funds to Chen from Houston Methodist Research Institute and a National Institutes of Health grant (R01AI106200) awarded to Li.

To speak with Wenhao Chen, Ph.D., contact Lisa Merkl, Houston Methodist, at 281-620-2502 or lmerkl@houstonmethodist.org. For more information about Houston Methodist, visit houstonmethodist.org. Follow us on Twitter and Facebook.

———————–
For more information: Ablation of Transcription Factor IRF4 Promotes Transplant Acceptance by Driving Allogenic CD4+ T Cell Dysfunction. Immunity DOI: http://dx.doi.org/10.1016/j.immuni.2017.11.003 (Dec. 19, 2017) J. Wu, H. Zhang, X. Shi, X. Xiao, Y. Fan, L.J. Minze, J. Wang, R.M. Ghobrial, J. Xia, R. Sciammas, X.C. Li and W. Chen.

###

Tags | Research



Social Posts

profile_image

Veterans Affairs

@DeptVetAffairs

Get involved with the 2018 National Veterans Creative Artists Festival https://t.co/dDJW3XnnGP via @Militarydotcom

30 mins ago
profile_image

UTHealth

@UTHealth

RT @UH_Pharmacy: Save the Date: UHCOP & @UTHealth's Houston Medication Safety Symposium to offer free CE & experts in geriatric polypharmac…

53 mins ago
profile_image

TAMU Health Sciences

@TAMHSC

A professor with @TAMU_SPH is pioneering WHO ethical guidelines https://t.co/FwUw6vdK5I

54 mins ago
profile_image

MD Anderson Cancer Center

@MDAndersonNews

Insights on the diagnosis and staging of follicular #lymphoma from our expert @DrNathanFowler:… https://t.co/BUFxfzGATG

60 mins ago
profile_image

BCMHouston

@bcmhouston

Did you know that 1 in 26 people will develop epilepsy in his or her lifetime? Learn more about epilepsy and some t… https://t.co/IcfWUqp9si

1 hour ago
profile_image

Baylor College of Medicine

BaylorCollegeOfMedicine

Be hair aware! See why Millennials are losing hair earlier in life. #Millennials

1 hour ago
profile_image

Veterans Affairs

@DeptVetAffairs

Danielle Corazza, our Center for Women Veterans' National Outreach Coordinator talks about her military service, be… https://t.co/aNzuJqAvYT

1 hour ago
profile_image

TexasHeartInstitute

@Texas_Heart

RT @OpticalSociety: Published today in #OSA_BOEx, a new #imaging technique may be first step to developing & testing therapies for healing…

1 hour ago
profile_image

Texas Children's Hospital

TexasChildrensHospital

Do you know what to research when looking for a new physician or hospital for your child? Learn more:

1 hour ago
profile_image

TexasHeartInstitute

@Texas_Heart

Study finds hot yoga is no better for your heart than traditional yoga. https://t.co/FchapltrO1

2 hours ago
profile_image

Rice University

@RiceUniversity

.@BakerInstitute expert explores surge of state gross receipts tax proposals | https://t.co/zzTYLSeQsw https://t.co/Vrz4WsFGJ1

2 hours ago
profile_image

Rice University

RiceUniversity

“History has many strange twists." Rice University - School of Engineering Professor Frank Tittel has been at Rice University for 50 years! He recently shared...

2 hours ago
profile_image

TAMU Health Sciences

@TAMHSC

Researchers at @TAMUmedicine showed how muscles “request" more energy from fat storage tissues in fruit fly models https://t.co/0jhDFdPtVy

2 hours ago
profile_image

Houston Methodist

@MethodistHosp

3.23, 7 a.m.-5 p.m.: Join @MethodistHosp for the Exploring Frontiers in the Management of Digestive & Liver Disorde… https://t.co/4agSgatiPV

2 hours ago
profile_image

MD Anderson Cancer Center

MDAnderson

What's your best advice for a cancer patient struggling with fatigue? #endcancer

2 hours ago